1 |
Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7
DOI
ScienceOn
|
2 |
Padilla J, Calvo V, Penalver JC, Sales G, Morcillo A. Surgical results and prognostic factors in early non-small cell lung cancer. Ann Thorac Surg 1997;63:324-6
DOI
ScienceOn
|
3 |
Padilla J, Calvo V, Penalver JC, et al. Survival and risk model for stage IB non-small cell lung cancer. Lung Cancer 2002;36:43-8
DOI
ScienceOn
|
4 |
Kang JH, Kim KD, Chung KY. Prognostic valve of visceral pleura invasion in non-small cell lung cancer. Eur J Cardiothorac Surg 2003;23:865-9
DOI
ScienceOn
|
5 |
Shimizu K, Yoshida J, Nagai K, et al. Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment. J Thorac Cardiovasc Surg 2004;127:1574-8
DOI
ScienceOn
|
6 |
Kato H, Ichinose Y, Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004;350:1713-21
DOI
ScienceOn
|
7 |
Carbone E, Asamura H, Takei H, et al. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer. J Thorac Cardiovasc Surg 2001;122:907-12
DOI
ScienceOn
|
8 |
Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon J, Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-60
DOI
PUBMED
ScienceOn
|
9 |
Ponn B, LoCicero III J, Daly BT. Surgical treatment of non-small cell lung cancer. In: Shields TW, Locicero III J, Ponn RB, Rusch VW. General thoracic surgery. 6th ed. Phiiladelphia: Wolters Kluver Co. 2005;1548-87
|
10 |
Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer. Chest 2002;122: 1037-57
DOI
ScienceOn
|
11 |
Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-9
DOI
ScienceOn
|
12 |
Naruke T, Tsuchiya R, Kondo H, Asamura H. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg 2001;71:1759-64
DOI
ScienceOn
|
13 |
Takeda S, Fukai S, Komatsu H, Nemoto E, Nakamura K, Murakami M. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer. Ann Thorac Surg 2005;79: 1142-6
DOI
ScienceOn
|
14 |
Cangir AK, Kutlay H, Akal M, Gungor A, Ozdemir N, Akay H. Prognostic value of tumor size in non-small cell lung cancer larger than five centimeters in diameter. Lung Cancer 2004;46:325-31
DOI
ScienceOn
|
15 |
Jones DR, Daniel TM, Denlinger CE, Rundall BK, Smolkin ME, Wick MR. Stage IB nonsmall cell lung cancers: are they all the same? Ann Thorac Surg 2006; 81:1958-62
DOI
ScienceOn
|
16 |
Lafitte JJ, Ribet ME, Prevost BM, Gosselin BH, Copin MC, Brichet AH. Postresection irradiation for T2N0M0 non-small cell carcinoma: a prospective, randomized study. Ann Thorac Surg 1996;62:830-4
DOI
ScienceOn
|
17 |
Ichinose Y, Hara N, Ohta M, et al. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer? J Thorac Cardiovasc Surg 1993;106:90-4
PUBMED
|